DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Kulkarni U, Ganesan S, Alex AA. et al
A phase II study evaluating the role of bortezomib in the management of relapsed acute promyelocytic leukemia treated upfront with arsenic trioxide.
Cancer Med 2020;
9 (08) 2603-2610
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.